Self-medication with analgesics reported by patients with ulcerative colitis: An anonymous survey

Gómez-Acebo, 2018, Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study, BMC Public Health, 18, 1134, 10.1186/s12889-018-6019-z Agencia Española de Medicamentos y Productos Sanitarios – Medicamentos de Uso Humano – Observatorio del Uso de Medicamentos de la AEMPS – Informes publicados. Available from: https://www.aemps.gob.es/medicamentos-de-uso-humano/observatorio-de-uso-de-medicamentos/utilizacion-de-medicamentos-analgesicos-no-opioides-en-espana-durante-el-periodo-2010-2018/ [accessed 28.09.20]. Sostres, 2013, Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage, Arthritis Res Ther, 15, S3, 10.1186/ar4175 Watanabe, 2020, Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review, J Gastroenterol, 55, 481, 10.1007/s00535-019-01657-8 Vinsard, 2017, Nonsteroidal anti-inflammatory drug-induced protein-losing enteropathy: a great masquerade of Crohn's disease, Gastrointest Endosc, 86, 1180, 10.1016/j.gie.2017.05.017 Ananthakrishnan, 2018, Environmental triggers in IBD: a review of progress and evidence, Nat Rev Gastroenterol Hepatol, 15, 39, 10.1038/nrgastro.2017.136 Buckley, 2013, The burden of comedication among patients with inflammatory bowel disease, Inflamm Bowel Dis, 19, 2725, 10.1097/01.MIB.0000435442.07237.a4 Long, 2016, Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease, J Clin Gastroenterol, 50, 152, 10.1097/MCG.0000000000000421 Bernstein, 2010, A prospective population-based study of triggers of symptomatic flares in IBD, Am J Gastroenterol, 105, 1994, 10.1038/ajg.2010.140 Bonner, 2004, A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease, Inflamm Bowel Dis, 10, 751, 10.1097/00054725-200411000-00009 Moninuola, 2018, Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn's disease and ulcerative colitis exacerbation, Aliment Pharmacol Ther, 47, 1428, 10.1111/apt.14606 Harbord, 2016, The first european evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease, J Crohns Colitis, 10, 239, 10.1093/ecco-jcc/jjv213 Maaser, 2017, European Crohn's and colitis organisation topical review on environmental factors in IBD, J Crohns Colitis, 11, 905, 10.1093/ecco-jcc/jjx002.038 Targownik, 2014, The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis, Am J Gastroenterol, 109, 1613, 10.1038/ajg.2014.230 Lichtenstein, 2012, Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry, Am J Gastroenterol, 107, 1409, 10.1038/ajg.2012.218 Lamb, 2019, British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults, Gut, 68, s1, 10.1136/gutjnl-2019-318484 Dipyrone. Drugs and Lactation Database (LactMed). Bethesda (MD): National Library of Medicine (US), 2006. Zeitz, 2016, Pain in IBD patients: very frequent and frequently insufficiently taken into account, PLOS ONE, 11, e0156666, 10.1371/journal.pone.0156666 Schirbel, 2010, Impact of pain on health-related quality of life in patients with inflammatory bowel disease, World J Gastroenterol, 16, 3168, 10.3748/wjg.v16.i25.3168 Mesonero, 2021, Self-medication with oral corticosteroids reported by patients with ulcerative colitis: characteristics, reasons and patients’ behaviors, Eur J Gastroenterol Hepatol, 33, 501, 10.1097/MEG.0000000000001931 Coates, 2013, Abdominal pain in ulcerative colitis, Inflamm Bowel Dis, 19, 2207, 10.1097/MIB.0b013e31829614c6 Andrade, 2016, Safety of metamizole: a systematic review of the literature, J Clin Pharm Ther, 41, 459, 10.1111/jcpt.12422 Leach, 2014, The effect of an inflammatory bowel disease nurse position on service delivery, J Crohns Colitis, 8, 370, 10.1016/j.crohns.2013.09.018 Molander, 2018, The impacts of an inflammatory bowel disease nurse specialist on the quality of care and costs in Finland, Scand J Gastroenterol, 53, 1463, 10.1080/00365521.2018.1541477 Halpin, 2012, Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis, Am J Gastroenterol, 107, 1474, 10.1038/ajg.2012.260 Calvet, 2020, Improving quality of care in inflammatory bowel disease through patients’ eyes: IQCARO project, Inflamm Bowel Dis, 26, 782, 10.1093/ibd/izz126 Lanas, 1992, Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding, Gastroenterology, 103, 862, 10.1016/0016-5085(92)90018-T